You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRVO

Showing 1 - 25 of 100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Central Retinal Vein Occlusion Trial in Paris, Strasbourg, Écully (Ophthalmologic exam at inclusion and 12 months after CRVO,

Recruiting
  • Central Retinal Vein Occlusion
  • Ophthalmologic exam at inclusion and 12 months after CRVO
  • Treatment standardization with aflibercept
  • Paris, France
  • +2 more
Oct 19, 2021

Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,

Recruiting
  • Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
  • intravitreal injection of Ranibizumab
  • +3 more
  • Qinā, Qena, Egypt
    Ahmed Ali Ahmed Amer
Mar 15, 2022

Use of Aflibercept Injections Into Eye for Treatment of Eye

Recruiting
  • Retinal Disease
  • Aflibercept (BAY86-5321, Eylea)
  • Multiple Locations, Mexico
    Many locations
Aug 22, 2022

Central Retinal Vein Occlusion Trial in TianJing (601 1.25mg, Ranibizuman 0.5 mg)

Not yet recruiting
  • Central Retinal Vein Occlusion
  • 601 1.25mg
  • Ranibizuman 0.5 mg
  • TianJing, TianJing, China
    TianJing Medical University Eye Hospital
Dec 8, 2020

Ophthalmopathy Trial in Asyut (Ranibizumab, triamcinolone acetate)

Unknown status
  • Ophthalmopathy
  • Asyut, Egypt
    Wael
Jul 2, 2020

Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)

Completed
  • Central Retinal Vein Occlusion
  • Stockholm, Sweden
    St Eriks Eye Hospital
Dec 3, 2020

Central Retinal Vein Occlusion Trial in Shenyang (Bevacizumab Ophthalmic and Intravitreal Dexamethasone., Bevacizumab

Unknown status
  • Central Retinal Vein Occlusion
  • Bevacizumab Ophthalmic and Intravitreal Dexamethasone.
  • Bevacizumab Ophthalmic.
  • Shenyang, Liaoning, China
    He Eye Specialist Hospital
Oct 20, 2020

Central Retinal Vein Occlusion Trial in Leuven (Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse)

Completed
  • Central Retinal Vein Occlusion
  • Vitrectomy with retinal vein cannulation and intravenous rtPA (Actilyse) infusion up to 1mg.
  • Intravenous Infusion
  • Leuven, Vlaams Brabant, Belgium
    UZ Leuven
May 6, 2020

Retinal Vein Occlusion Trial in France

Active, not recruiting
  • Retinal Vein Occlusion
    • Créteil, France
    • +8 more
    Aug 17, 2022

    Macular Edema, Retinal Vein Occlusion Trial in Assiut (Intravitreal injection of Dexamethasone implant)

    Recruiting
    • Macular Edema
    • Retinal Vein Occlusion
    • Intravitreal injection of Dexamethasone implant
    • Assiut, Egypt
      Faculty of medicine
    Feb 27, 2022

    Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])

    Completed
    • Central Retinal Vein Occlusion With Macular Edema
    • Ziv-Aflibercept 25 MG/ML [Zaltrap]
    • Tanta, El Gharbia, Egypt
      Tanta University
    Oct 4, 2021

    Central Retinal Vein Occlusion Trial in Worldwide (Aflibercept (Eylea, BAY86-5321))

    Completed
    Has Results
    • Central Retinal Vein Occlusion
    • Aflibercept (Eylea, BAY86-5321)
    • Albury, New South Wales, Australia
    • +41 more
    Jun 19, 2020

    Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion Trial in Palo Alto (nicotinic acid)

    Terminated
    Has Results
    • Central Retinal Vein Occlusion
    • Branch Retinal Vein Occlusion
    • nicotinic acid
    • Palo Alto, California
      Palo Alto Medical Foundation Department of Ophthalmology
    Oct 21, 2019

    Retinal Vein Occlusion, Macula Edema Trial in United States (TLC399 (ProDex))

    Completed
    Has Results
    • Retinal Vein Occlusion
    • Macula Edema
    • TLC399 (ProDex)
    • Phoenix, Arizona
    • +19 more
    Nov 24, 2021

    Prospective, Non-interventional, Multi-center Post-authorization

    Completed
    • Retinal Vein Occlusion
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Japan
      (unnamed)
    Apr 9, 2019

    Central Retinal Vein Occlusion With Macular Edema Trial in Germany (Ranibizumab Injection, Laser photocoagulation)

    Recruiting
    • Central Retinal Vein Occlusion With Macular Edema
    • Ranibizumab Injection
    • Laser photocoagulation
    • Dresden, Germany
    • +13 more
    May 5, 2022

    Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham

    Active, not recruiting
    • Macular Edema
    • +2 more
    • Mesa, Arizona
    • +193 more
    Jul 25, 2022

    Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)

    Completed
    Has Results
    • Central Retinal Vein Occlusion With Macular Edema
    • Group A
    • Peshawar, KPK, Pakistan
      Hayatabad Medical Complex
    Apr 3, 2022

    Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

    Active, not recruiting
    • Macular Edema
    • Retinal Vein Occlusion
    • Phoenix, Arizona
    • +140 more
    Jul 20, 2022

    Central Retinal Vein Occlusion With Macular Edema, Branch Retinal Vein Occlusion With Macular Edema Trial in Taiwan (TLC399)

    Completed
    Has Results
    • Central Retinal Vein Occlusion With Macular Edema
    • Branch Retinal Vein Occlusion With Macular Edema
    • Chang Hua, Taiwan
    • +5 more
    Nov 24, 2021

    Retinal Vein Occlusion Trial in Bethesda, Bristol (Minocycline, Placebo, Bevacizumab)

    Completed
    Has Results
    • Retinal Vein Occlusion
    • Bethesda, Maryland
    • +1 more
    Feb 25, 2021

    Central Retinal Vein Occlusion Trial in United States (aflibercept, bevacizumab)

    Completed
    Has Results
    • Central Retinal Vein Occlusion
    • Phoenix, Arizona
    • +71 more
    Jun 11, 2021

    Retinal Vein Occlusion Trial in Palo Alto (Nicotinic acid, Prednisolone acetate)

    Completed
    Has Results
    • Retinal Vein Occlusion
    • Nicotinic acid
    • Prednisolone acetate
    • Palo Alto, California
      Palo Alto Medical Foundation Department of Ophthalmology
    Dec 18, 2018

    Study of Retinal Oxygenation in Central Retinal Vein Occlusion

    Completed
    • Retinal Vein Occlusion
      • Vienna, Austria
      • +7 more
      Feb 11, 2021

      Patients Treated for Macular Edema Due to Central Retinal Vein

      Completed
      • Retinal Vein Occlusion
      • Aflibercept (Eylea, BAY86-5321)
      • Multiple Locations, Belgium
        (unnamed)
      Sep 4, 2018